Medicamen Biotech gets manufacturing license for oncology formulation plant

27 Jul 2020 Evaluate
Medicamen Biotech has received manufacturing license for its Oncology Formulation Plant situated at Haridwar in Uttarakhand, from Drug Controlling & Licensing Authority, Uttarakhand.
 
Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Medicamen Biotech Share Price

251.10 -9.90 (-3.79%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×